Cargando…
Treat-to-target urate-lowering therapy and hospitalizations for gout: results from a nationwide cohort study in England
OBJECTIVE: To investigate associations between treat-to-target urate-lowering therapy (ULT) and hospitalizations for gout. METHODS: Using linked Clinical Practice Research Datalink and NHS Digital Hospital Episode Statistics data, we described the incidence and timing of hospitalizations for flares...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321109/ https://www.ncbi.nlm.nih.gov/pubmed/36355461 http://dx.doi.org/10.1093/rheumatology/keac638 |
_version_ | 1785068562621136896 |
---|---|
author | Russell, Mark D Roddy, Edward Rutherford, Andrew I Ellis, Benjamin Norton, Sam Douiri, Abdel Gulliford, Martin C Cope, Andrew P Galloway, James B |
author_facet | Russell, Mark D Roddy, Edward Rutherford, Andrew I Ellis, Benjamin Norton, Sam Douiri, Abdel Gulliford, Martin C Cope, Andrew P Galloway, James B |
author_sort | Russell, Mark D |
collection | PubMed |
description | OBJECTIVE: To investigate associations between treat-to-target urate-lowering therapy (ULT) and hospitalizations for gout. METHODS: Using linked Clinical Practice Research Datalink and NHS Digital Hospital Episode Statistics data, we described the incidence and timing of hospitalizations for flares in people with index gout diagnoses in England from 2004–2020. Using Cox proportional hazards and propensity models, we investigated associations between ULT initiation, serum urate target attainment, colchicine prophylaxis, and the risk of hospitalizations for gout. RESULTS: Of 292 270 people with incident gout, 7719 (2.64%) had one or more hospitalizations for gout, with an incidence rate of 4.64 hospitalizations per 1000 person-years (95% CI 4.54, 4.73). There was an associated increased risk of hospitalizations within the first 6 months after ULT initiation, when compared with people who did not initiate ULT [adjusted Hazard Ratio (aHR) 4.54; 95% CI 3.70, 5.58; P < 0.001]. Hospitalizations did not differ significantly between people prescribed vs not prescribed colchicine prophylaxis in fully adjusted models. From 12 months after initiation, ULT associated with a reduced risk of hospitalizations (aHR 0.77; 95% CI 0.71, 0.83; P < 0.001). In ULT initiators, attainment of a serum urate <360 micromol/l within 12 months of initiation associated with a reduced risk of hospitalizations (aHR 0.57; 95% CI 0.49, 0.67; P < 0.001) when compared with people initiating ULT but not attaining this target. CONCLUSION: ULT associates with an increased risk of hospitalizations within the first 6 months of initiation but reduces hospitalizations in the long term, particularly when serum urate targets are achieved. |
format | Online Article Text |
id | pubmed-10321109 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-103211092023-07-06 Treat-to-target urate-lowering therapy and hospitalizations for gout: results from a nationwide cohort study in England Russell, Mark D Roddy, Edward Rutherford, Andrew I Ellis, Benjamin Norton, Sam Douiri, Abdel Gulliford, Martin C Cope, Andrew P Galloway, James B Rheumatology (Oxford) Clinical Science OBJECTIVE: To investigate associations between treat-to-target urate-lowering therapy (ULT) and hospitalizations for gout. METHODS: Using linked Clinical Practice Research Datalink and NHS Digital Hospital Episode Statistics data, we described the incidence and timing of hospitalizations for flares in people with index gout diagnoses in England from 2004–2020. Using Cox proportional hazards and propensity models, we investigated associations between ULT initiation, serum urate target attainment, colchicine prophylaxis, and the risk of hospitalizations for gout. RESULTS: Of 292 270 people with incident gout, 7719 (2.64%) had one or more hospitalizations for gout, with an incidence rate of 4.64 hospitalizations per 1000 person-years (95% CI 4.54, 4.73). There was an associated increased risk of hospitalizations within the first 6 months after ULT initiation, when compared with people who did not initiate ULT [adjusted Hazard Ratio (aHR) 4.54; 95% CI 3.70, 5.58; P < 0.001]. Hospitalizations did not differ significantly between people prescribed vs not prescribed colchicine prophylaxis in fully adjusted models. From 12 months after initiation, ULT associated with a reduced risk of hospitalizations (aHR 0.77; 95% CI 0.71, 0.83; P < 0.001). In ULT initiators, attainment of a serum urate <360 micromol/l within 12 months of initiation associated with a reduced risk of hospitalizations (aHR 0.57; 95% CI 0.49, 0.67; P < 0.001) when compared with people initiating ULT but not attaining this target. CONCLUSION: ULT associates with an increased risk of hospitalizations within the first 6 months of initiation but reduces hospitalizations in the long term, particularly when serum urate targets are achieved. Oxford University Press 2022-11-10 /pmc/articles/PMC10321109/ /pubmed/36355461 http://dx.doi.org/10.1093/rheumatology/keac638 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Science Russell, Mark D Roddy, Edward Rutherford, Andrew I Ellis, Benjamin Norton, Sam Douiri, Abdel Gulliford, Martin C Cope, Andrew P Galloway, James B Treat-to-target urate-lowering therapy and hospitalizations for gout: results from a nationwide cohort study in England |
title | Treat-to-target urate-lowering therapy and hospitalizations for gout: results from a nationwide cohort study in England |
title_full | Treat-to-target urate-lowering therapy and hospitalizations for gout: results from a nationwide cohort study in England |
title_fullStr | Treat-to-target urate-lowering therapy and hospitalizations for gout: results from a nationwide cohort study in England |
title_full_unstemmed | Treat-to-target urate-lowering therapy and hospitalizations for gout: results from a nationwide cohort study in England |
title_short | Treat-to-target urate-lowering therapy and hospitalizations for gout: results from a nationwide cohort study in England |
title_sort | treat-to-target urate-lowering therapy and hospitalizations for gout: results from a nationwide cohort study in england |
topic | Clinical Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321109/ https://www.ncbi.nlm.nih.gov/pubmed/36355461 http://dx.doi.org/10.1093/rheumatology/keac638 |
work_keys_str_mv | AT russellmarkd treattotargeturateloweringtherapyandhospitalizationsforgoutresultsfromanationwidecohortstudyinengland AT roddyedward treattotargeturateloweringtherapyandhospitalizationsforgoutresultsfromanationwidecohortstudyinengland AT rutherfordandrewi treattotargeturateloweringtherapyandhospitalizationsforgoutresultsfromanationwidecohortstudyinengland AT ellisbenjamin treattotargeturateloweringtherapyandhospitalizationsforgoutresultsfromanationwidecohortstudyinengland AT nortonsam treattotargeturateloweringtherapyandhospitalizationsforgoutresultsfromanationwidecohortstudyinengland AT douiriabdel treattotargeturateloweringtherapyandhospitalizationsforgoutresultsfromanationwidecohortstudyinengland AT gullifordmartinc treattotargeturateloweringtherapyandhospitalizationsforgoutresultsfromanationwidecohortstudyinengland AT copeandrewp treattotargeturateloweringtherapyandhospitalizationsforgoutresultsfromanationwidecohortstudyinengland AT gallowayjamesb treattotargeturateloweringtherapyandhospitalizationsforgoutresultsfromanationwidecohortstudyinengland |